Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer - a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System

Erstveröffentlichung

2010

Authors

Lux, Michael P.

Wöckel, Achim

Benedict, Agnes

Buchholz, Stefan

Kreif, Noemi

et al.

Wissenschaftlicher Artikel

Published in

Onkologie ; 33 (2010), 4. - S. 155-166. - ISSN 0378-584X. - eISSN 1423-0240

Link to publication

https://dx.doi.org/10.1159/000286233

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[Free subject headings]: Anastrozole | Cost-effectiveness analysis | Cost-utility analysis | Incremental cost-effectiveness ratio | Tamoxifen | QALY | POSTMENOPAUSAL WOMEN | AROMATASE INHIBITORS | ENDOCRINE THERAPY | UTILITIES | LETROZOLE | MORTALITY
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record